Profile: Dean Buonomano Studies How the Brain Encodes Time

The UCLA neurobiologist uses computational modeling, in vitro electrophysiology, and human psychophysics experiments to explore how neurons and the brain as a whole perceive and respond to time.

Written byAnna Azvolinsky
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

DEAN BUONOMANO
Professor of Behavioral Neuroscience, Neurobiology Brain Research Institute
University of California, Los Angeles
COURTESY OF DEAN BUONOMANO
Dean Buonomano was among the first neuroscientists to begin to ask how the human brain encodes time. It’s not an easy concept to grasp, Buonomano says, and for that reason many researchers overlook it. “The first field of modern science was probably geometry, which was formalized by Euclid around 300 B.C.,” says the researcher, who is currently working on a popular-science book about time and the brain. “What’s amazing about geometry is that there is absolutely no time involved; it’s the study of things that never change. And there’s a reason why it is one of the first science fields. Science is much easier if you can ignore time.”

Buonomano was in grad school when he became enamored of the question of how we navigate through time. As a graduate student at the University of Texas (UT) Health Science Center at Houston, Buonomano collaborated with Michael Mauk after he heard Mauk’s lecture on his studies of the neural circuits in the cerebellum. “He had really transformative ideas about how the cerebellum tells time and how the dynamics of neural circuits in the cerebellum might code for timing,” says Buonomano. “His ideas were really something that directed the rest of my career.”

Mauk and Buonomano modeled the way the cerebellum’s circuits could respond to stimuli and showed that this type of neuronal network can differentiate between time intervals that differ by just tens of milliseconds. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies